Lung Cancer News

Lung cancer is the leading cause of cancer mortality worldwide, and it is responsible for more deaths than colon, prostate and breast cancers combined.

The FDA granted priority review to nivolumab for use with chemotherapy as neoadjuvant treatment of patients with resectable non-small cell lung cancer.

Rare Disease Day is Feb. 28.

Only 7.5% of oncology trials conducted between 2008 and 2020 investigated surgical interventions, according to study results published in JAMA Network Open.

The FDA approved FoundationOne CDx as a companion diagnostic to identify patients with microsatellite instability-high solid tumors who may benefit from pembrolizumab, according to a press release from the test’s manufacturer.

Memorial Sloan Kettering Cancer Center placed a pause on a phase 1 clinical trial of ATA2271 — a chimeric antigen receptor T-cell therapy — after one patient treated with the investigational therapy died.

National lung cancer screening rates remained low and unchanged from 2019 to 2020, but rates significantly improved in 19 U.S. states despite the COVID-19 pandemic, according to data published in Chest.

Patients newly diagnosed with cancer and considered to be of high socioeconomic status had the highest use of telemedicine in the early days of the COVID-19 pandemic, according to a research letter published in JAMA Oncology.

Current treatments for thymic cancers did not significantly increase risk for cardiovascular disease, according to study results presented at American College of Cardiology’s Advancing the Cardiovascular Care of the Oncology Patient.

Breast cancer has surpassed lung cancer as the leading cause of cancer-associated death among Black women in the U.S., according to an American Cancer Society report.